))
Episode 47: Oscar Segurado- CMO at ASC Therapeutics
Manage episode 387762712 series 3526490
Contenido proporcionado por Vial. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Vial o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Ever wondered how far we've truly come in the realm of gene and cell therapies, and where we're headed next? This captivating conversation with Oscar Segurado, the CMO of ASC Therapeutics, will satisfy your curiosity. Oscar, a veteran in the biopharmaceutical industry, shares fascinating insights on ASC Therapeutics' groundbreaking innovation in personalized medicine and synthetic biology as they set out to redefine the future of therapies for rare diseases.
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.
Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: https://vial.com
Follow us on social media for real-time insights:
Twitter: https://twitter.com/VialTrials
LinkedIn: https://www.linkedin.com/company/vialtrials
Capíttulos
1. Episode 47: Oscar Segurado- CMO at ASC Therapeutics (00:00:00)
2. Revolutionary Gene and Cell Therapies (00:00:06)
3. Future of Gene and Cell Therapies (00:12:03)
4. Success in ASI ARO With Oscar (00:21:16)
62 episodios
Compartir
